Mediliant Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-01-2025
- Paid Up Capital ₹ 1.00 Cr
as on 03-01-2025
- Company Age 5 Year, 29 Days
- Open Charges ₹ 7.66 Cr
as on 03-01-2025
- Satisfied Charges ₹ 2.65 Cr
as on 03-01-2025
About Mediliant Life Science
The Corporate was formerly known as Surya Pro Packs Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.66 Cr. The company has closed loans amounting to ₹2.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitin Garg, Sushila Garg, Sonam Garg, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100UR2019PTC010523
- Company No.
010523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2019
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mediliant Life Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Garg  | Director | 13-Dec-2019 | Current |
| Sushila Garg | Director | 21-May-2024 | Current |
| Sonam Garg | Director | 21-May-2024 | Current |
| Preeti Jain | Additional Director | 21-May-2024 | Current |
| Nitesh Jain | Additional Director | 08-Dec-2021 | Current |
Financial Performance of Mediliant Life Science.
Enhance accessibility to Mediliant Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mediliant Life Science?
Unlock access to Mediliant Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Dec 2024 | ₹7.66 Cr | Open |
Sidbi Creation Date: 08 Apr 2021 | ₹1.15 Cr | Satisfied |
Sidbi Creation Date: 08 Apr 2021 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Mediliant Life Science?
Unlock and access historical data on people associated with Mediliant Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediliant Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediliant Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
